Debevoise & Plimpton LLP

Predominantly working out of the New York office, Debevoise & Plimpton LLP‘s team is noted for its focus on private equity transactions within the healthcare and life sciences spaces. The group regularly advises on equity and debt financing arrangements, and class actions concerning overbilling practices. Key names within the team include corporate and M&A expert Andrew Bab, and Paul Rubin, who leads the FDA regulatory team from Washington DC. Mark Goodman and Maura Monaghan are noted for their expertise in commercial litigation, with Goodman standing out for his experience in handling white-collar crime matters and government investigations. Kevin Rinker and Jennifer Chu are both known for their expansive knowledge of M&A and private equity buyouts within the healthcare and life sciences sectors.